Brain Neoplasms, Primary Malignant Clinical Trial
Official title:
Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers
| NCT number | NCT01638130 |
| Other study ID # | B322201110320 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | July 6, 2012 |
| Last updated | July 11, 2012 |
| Start date | February 2011 |
The purpose of this study is to explore the experiences and needs of patients with a high-grade glioma and their caregivers. Semi-structured interviews with patients and caregivers will be conducted and analysed using Grounded-Theory approach.
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Adults - Patients with a primary high-grade glioma who are treated with chemo or were treated with chemo - Caregivers of patients with a primary high-grade glioma who are treated with chemo or were treated with chemo - Able to be interviewed - Dutch Exclusion Criteria: - Patients with cerebral metastases - Patients and caregivers who withdraw their informed consent - Emotionally and cognitive not being able to be interviewed |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Belgium | UZ Leuven | Leuven | Vlaams-Brabant |
| Lead Sponsor | Collaborator |
|---|---|
| Universitaire Ziekenhuizen Leuven |
Belgium,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00308165 -
Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors
|
Phase 1/Phase 2 |